Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome.
Abinun
M
M
Cant
A J
AJ
D001241:Aspirin / Q000627:therapeutic use; D002648:Child; D003131:Combined Modality Therapy; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D008297:Male; D009080:Mucocutaneous Lymph Node Syndrome / Q000150:complications* / Q000628:therapy; D012772:Shock, Septic / Q000150:complications* / Q000382:microbiology / Q000628:therapy; D013290:Streptococcal Infections / Q000150:complications* / Q000382:microbiology / Q000628:therapy; D013297:Streptococcus pyogenes
D016756:Immunoglobulins, Intravenous; D001241:Aspirin